Cargando…

Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists

We previously reported the design and synthesis of a small-molecule drug conjugate (SMDC) platform that demonstrated several advantages over antibody–drug conjugates (ADCs) in terms of in vivo pharmacokinetics, solid tumor penetration, definitive chemical structure, and adaptability for modular synt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Debnath, Sashi, Hao, Guiyang, Guan, Bing, Thapa, Pawan, Hao, Justin, Hammers, Hans, Sun, Xiankai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266369/ https://www.ncbi.nlm.nih.gov/pubmed/35806163 http://dx.doi.org/10.3390/ijms23137160

Ejemplares similares

A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer
por: Gonzalez, Paulina, et al.
Publicado: (2023)

PSMA-Targeting Imaging and Theranostic Agents—Current Status and Future Perspective
por: Debnath, Sashi, et al.
Publicado: (2022)

Small molecules and conjugates as theranostic agents
por: Pratihar, Sumon, et al.
Publicado: (2023)

Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy
por: Tang, Li, et al.
Publicado: (2019)

Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer
por: Guan, Bing, et al.
Publicado: (2021)

Synthesis and Immunological Characterization of Toll-Like Receptor 7 Agonistic Conjugates
por: Chan, Michael, et al.
Publicado: (2009)

Folic acid-CdTe quantum dot conjugates and their applications for cancer cell targeting
por: Suriamoorthy, Preethi, et al.
Publicado: (2010)

Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting
por: Lim, Jongdoo, et al.
Publicado: (2019)

A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate
por: Xiao, Dian, et al.
Publicado: (2021)

Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy
por: Wang, Huiyuan, et al.
Publicado: (2017)

From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
por: Wang, Yanming, et al.
Publicado: (2022)

DNA-supramolecule conjugates in theranostics
por: Chen, Kun, et al.
Publicado: (2019)

Conjugated polymer nanomaterials for theranostics
por: Qian, Cheng-gen, et al.
Publicado: (2017)

Cyanine conjugates in cancer theranostics
por: Li, Yang, et al.
Publicado: (2020)

Small Molecular Prodrug Amphiphile Self-Assembled AIE Dots for Cancer Theranostics
por: Yang, Xing, et al.
Publicado: (2020)

A novel glutathione-triggered theranostic prodrug for anticancer and imaging in living cells
por: Zhang, Hengrui, et al.
Publicado: (2018)

Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue
por: Corogeanu, Diana, et al.
Publicado: (2023)

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
por: Nock, Berthold A., et al.
Publicado: (2023)

Comparison of BMIPP-SPECT/CT to (18)FDG-PET/CT for Imaging Brown or Browning Fat in a Preclinical Model
por: Frankl, Joseph A., et al.
Publicado: (2022)

Glutathione S-conjugates as prodrugs to target drug-resistant tumors
por: Ramsay, Emma E., et al.
Publicado: (2014)

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
por: Yang, Jincheng, et al.
Publicado: (2018)

Dual-channel NIR activatable theranostic prodrug for in vivo spatiotemporal tracking thiol-triggered chemotherapy
por: Ye, Mingzhou, et al.
Publicado: (2016)

Utilization of Enzyme-Immobilized Mesoporous Silica Nanocontainers (IBN-4) in Prodrug-Activated Cancer Theranostics
por: Hung, Bau-Yen, et al.
Publicado: (2015)

Controlled sequential in situ self-assembly and disassembly of a fluorogenic cisplatin prodrug for cancer theranostics
por: Wen, Xidan, et al.
Publicado: (2023)

Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors
por: Moeendarbari, Sina, et al.
Publicado: (2016)

Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation
por: Bhagchandani, Sachin H., et al.
Publicado: (2023)

Integrated prodrug micelles with two-photon bioimaging and pH-triggered drug delivery for cancer theranostics
por: Xu, Hong, et al.
Publicado: (2020)

Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H(2)O(2) responsiveness for cancer theranostics
por: Mu, Xueluer, et al.
Publicado: (2023)

Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications
por: Banerjee, Shashwat S., et al.
Publicado: (2012)

Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
por: Li, Xuejiao, et al.
Publicado: (2018)

Antibiotic Conjugated Fluorescent Carbon Dots as a Theranostic Agent for Controlled Drug Release, Bioimaging, and Enhanced Antimicrobial Activity
por: Thakur, Mukeshchand, et al.
Publicado: (2014)

Cisplatin Prodrug-Conjugated Gold Nanocluster for Fluorescence Imaging and Targeted Therapy of the Breast Cancer
por: Zhou, Fangyuan, et al.
Publicado: (2016)

Sequential acid/reduction response of triblock copolymeric nanomicelles to release camptothecin and toll-like receptor 7/8 agonist for orchestrated chemoimmunotherapy
por: Ge, Xiaoyan, et al.
Publicado: (2022)

Small molecules as theranostic agents in cancer immunology
por: Li, Jindian, et al.
Publicado: (2019)

Conjugation of a Toll‐Like Receptor Agonist to Glycans of an HIV Native‐Like Envelope Trimer Preserves Neutralization Epitopes
por: Li, Zeshi, et al.
Publicado: (2022)

Microbubble–liposome conjugate: Payload evaluation of potential theranostic vehicle
por: Malik, Ritu, et al.
Publicado: (2016)

Flavonoid-Conjugated Gadolinium Complexes as Anti-Inflammatory Theranostic Agents
por: Yang, Byeong Woo, et al.
Publicado: (2022)

Peroxynitrite Activated Drug Conjugate Systems Based on a Coumarin Scaffold Toward the Application of Theranostics
por: Odyniec, Maria L., et al.
Publicado: (2019)

Antibody-Based Imaging of Bioreductive Prodrug Release in Hypoxia
por: Tosun, Çağla, et al.
Publicado: (2023)

TSPO Ligand-Methotrexate Prodrug Conjugates: Design, Synthesis, and Biological Evaluation
por: Laquintana, Valentino, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1rsfqb01td7hgpn65g95n5ha4m